Veristat Clinical Leader Solutions Expo May 2025: CRO Services – Oncology

Veristat, the Science-First™ full service CRO and consultancy, enables sponsors to solve the unique and complex challenges associated with accelerating therapies through clinical development onto regulatory approval and post-marketing. With our focus on novel drug development and 30 years of experience in clinical trial planning and execution, we deliver bold approaches that make the impossible possible. Our team has prepared over 100 marketing applications for approval with global regulatory authorities in the last 10 years alone. We supported the trials for the first gene therapy approved in Europe.

Veristat’s focus on novel drug development has led to success when handling the unknowns that arise across complicated therapeutic areas, such as rare/ultra-rare disease, advanced therapies, oncology, and infectious disease trials. We apply this knowledge base every day to solve any clinical program’s challenges, from the simplest to the most complex. Veristat has assembled an extraordinary team of experts worldwide who have mastered therapeutic development intricacies, enabling sponsors to succeed in extending and saving lives.

From complex study designs and evolving regulations to time-sensitive treatment protocols, advancing oncology clinical trials presents significant challenges for investigators, sites, and patients. Veristat offers the expertise and over 30 years’ experience to support you in navigating these complexities to your therapy’s approval and commercial success.